Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma

NCT02611700 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

504

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinomas

Interventions

DRUG: Nimotuzumab
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Placebo

Sponsor

Biotech Pharmaceutical Co., Ltd.